Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$62.17 - $97.62 $3.43 Million - $5.39 Million
-55,168 Reduced 62.66%
32,880 $3.21 Million
Q4 2022

Feb 14, 2023

BUY
$60.21 - $77.74 $560,434 - $723,603
9,308 Added 11.82%
88,048 $5.47 Million
Q3 2022

Nov 14, 2022

BUY
$72.92 - $99.73 $3.25 Million - $4.44 Million
44,502 Added 129.98%
78,740 $5.74 Million
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $2.03 Million - $3.55 Million
24,075 Added 236.89%
34,238 $3.24 Million
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $621,454 - $868,489
5,057 Added 99.04%
10,163 $1.41 Million
Q4 2021

Feb 14, 2022

BUY
$156.0 - $265.78 $796,536 - $1.36 Million
5,106 New
5,106 $932,000
Q3 2021

Nov 15, 2021

SELL
$228.69 - $274.2 $1.04 Million - $1.25 Million
-4,548 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $4.63 Million - $6.31 Million
-27,274 Reduced 85.71%
4,548 $1.05 Million
Q1 2021

May 17, 2021

BUY
$143.93 - $207.3 $4.25 Million - $6.13 Million
29,553 Added 1302.47%
31,822 $5.36 Million
Q4 2020

Feb 16, 2021

SELL
$96.1 - $151.18 $255,145 - $401,382
-2,655 Reduced 53.92%
2,269 $330,000
Q3 2020

Nov 16, 2020

BUY
$90.16 - $107.61 $443,947 - $529,871
4,924 New
4,924 $486,000
Q2 2020

Aug 14, 2020

SELL
$52.17 - $95.63 $345,730 - $633,740
-6,627 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$52.76 - $109.0 $7,386 - $15,260
140 Added 2.16%
6,627 $366,000
Q4 2019

Feb 14, 2020

SELL
$69.39 - $97.59 $1.35 Million - $1.9 Million
-19,443 Reduced 74.98%
6,487 $622,000
Q3 2019

Nov 14, 2019

SELL
$64.17 - $84.08 $1.08 Million - $1.41 Million
-16,816 Reduced 39.34%
25,930 $1.84 Million
Q2 2019

Aug 14, 2019

BUY
$70.1 - $85.17 $1.34 Million - $1.63 Million
19,105 Added 80.81%
42,746 $3.64 Million
Q1 2019

May 15, 2019

BUY
$77.0 - $99.34 $1.82 Million - $2.35 Million
23,641 New
23,641 $2.01 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.